Antiviral Drugs Market to Cross US$ 78 Bn in Revenues by the end of 2033 | According to Persistence Market Research New York, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Reverse Transcriptase Inhibitors to account for Over 50% of the Antiviral Drugs Sales in the Forthcoming Years, Forecasts Persistence Market Research ...